) --




) hit a new 52-week high Wednesday as it is currently trading at $7.89, above its previous 52-week high of $7.88 with 431,587 shares traded as of 11:26 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Affymetrix has a market cap of $542.2 million and is part of the


sector and


industry. Shares are up 55.3% year to date as of the close of trading on Tuesday.

Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.

  • Practice your AFFX trading strategies and win cash in our stock game.

TheStreet Ratings rates Affymetrix as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that revenues have generally been declining. You can view the full

Affymetrix Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center